(Q34162158)

31 July 2017

1 reference

title

Screening for cancer in viral hepatitis (English)

1 reference

31 July 2017

Colombo M

1

1 reference

31 July 2017

publication date

1 February 2001

1 reference

31 July 2017

published in

Clinics in liver disease

1 reference

31 July 2017

volume

5

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

109-122

1 reference

Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Hepatitis B virus. The major etiology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Small hepatocellular carcinomas in cirrhotic explant livers: identification by macroscopic examination and lipiodol localization

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Ultrasonography-detected macroregenerative nodules in cirrhosis: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Hepatocellular carcinoma in Italian patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

The natural history of asymptomatic hepatitis B surface antigen carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Detection of malignant tumors in end-stage cirrhotic livers: efficacy of sonography as a screening technique

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Chronic type B hepatitis and the "healthy" HBsAg carrier state

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Small hepatic nodules in cirrhosis: ultrasonographic, CT, and MR imaging findings

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Analysis of cost-effectiveness of different strategies for hepatocellular carcinoma screening in hepatitis B virus carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Differential diagnosis of small hepatocellular carcinoma and adenomatous hyperplasia with power Doppler sonography

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Morbidity and mortality from chronic hepatitis B virus infection in family members of patients with malignant and nonmalignant hepatitis B virus–related chronic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Workshop on Screening for Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Dynamic MR imaging and early-phase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Screening for hepatocellular carcinoma in high-risk individuals. A clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Hepatitis C virus genotype 1b and risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Minus strand RNA of hepatitis C virus liver tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970156-2

7 January 2021

10.1016/S1089-3261(05)70156-2

Identifiers

DOI

1 reference

31 July 2017

1 reference